spinal News
-
Spinal Cord Injury (SCI) Awareness Month
September is National Spinal Cord Injury (SCI) Awareness Month. With over 17,000 new spinal cord injuries taking place every year in the U.S., there is a significant need to call attention to the severity of spinal cord injuries and for continued research to aid in finding a cure. To sustain an SCI is extremely traumatic for the individual, and it also takes a toll on their family, friends, ...
-
Incidence of traumatic lumbar punctures in neonates and infants
Our whitepaper takes a closer look at the lumbar puncture, the IQ-Tip system’s first indication, and presents the results that Injeq has obtained with the system. We discuss the various advantages that the system provides compared to a conventional spinal needle. You can download the white paper here: Clinical applications for the IQ-Tip system and their potential benefits ...
By Injeq Oy
-
What do clinical experts say about the ABLE Exoskeleton?
We interviewed Prof. Dr. Ing. Rüdiger Rupp, a key opinion leader in the field of rehabilitation technology with more than 25 years of clinical experience, to talk about rehabilitation, exoskeleton technology, clinical trials and many more. Prof. Dr. Ing. Rüdiger Rupp is the Head of Experimental Neurorehabilitation at the Heidelberg University Hospital in Germany. Throughout his ...
-
August 2022 is Spinal Muscular Atrophy Awareness Month!
Every year, the month of August is nationally recognized as Spinal Muscular Atrophy (SMA) Awareness Month. This month-long awareness campaign serves as an important time to demonstrate support and help promote awareness for this rare disease affecting lives across the world. WHAT IS SMA? Affecting 4 people in every 100,000 in the U.S., Spinal Muscular Atrophy (SMA) is a genetic, progressive ...
-
Design freeze of ABLE Exoskeleton
After creating 7 iterative versions of the exoskeleton prototype that have been tested in individuals with spinal cord injury to validate product-market fit and receive early feedback in order to adapt, change and redesign the device, we have frozen the design of the ABLE Exoskeleton. The final design will be revealed at RehabWeek, the leading conference in rehabilitation technology, in Rotterdam ...
-
Meagan Medical Inc. Announces Issuance of a Key U.S. Patent for a Disruptive Chronic Pain Treatment using Spinal Cord Stimulation
Patent provides protection for High Frequency Spinal Cord Stimulation with Beat Technology Vancouver, Washington – March 20, 2015 – Meagan Medical Inc., a clinical research and medical device development company focused on investigating and developing optimal ways of managing and controlling pain, announced today the issuance of a key patent related to a unique ...
-
Optimizing Patient Outcomes - Tips from Advanced Practice Provider to Communicate Appropriate Patient Expectations After the mild Treatment
As an Advanced Practice Provider (APP), you are an integral part in helping patients with lumbar spinal stenosis (LSS) get on the path to lasting relief. In this webinar workshop, led by our panel of mild® experts, APPs Ashley Comer, NP, Marie Zambelli, NP, Kelsey Kimball, PA, Lauren Cote, NP, Patrick McGinn, PA, Kristen Klein, NP, discuss how patient education and proper outcomes assessment ...
-
FARCO-PHARMA supports “Protect the vulnerable“
Europe-wide aid project for the protection of people with paraplegia Cologne, 28/05/2020 – COVID-19 can be particularly dangerous for people with severe spinal cord injuries. That is why FARCO-PHARMA supports the European Spinal Cord Injury Federation (ESCIF) and the Association of Paraplegics in Germany e.V. (FGQ) with the supply of free protective masks for the caregivers of this ...
-
Vybion Huntington`s Disease Drug Patent receives Track I Status
Vybion, Inc. is pleased to announce that its patent application covering methods of use and composition for INT41 Gene Therapy received Track I status from the USPTO. The INT41 patent application covers several neurodegenerative diseases in addition to Huntington's Disease including Spinal Cerebellar Ataxia, Spinal Muscular Atrophy, and Alzheimer's. "Vybion is pleased to receive Track I status on ...
By Vybion
-
Excite Medical and CEO Saleem Musallam showcase DRX9000 at FCA NE chiropractic convention
Excite Medical, the leading provider of non-surgical spinal decompression machines for back pain and neck pain, recently showcased its innovative and groundbreaking DRX9000® spinal decompression machine at the Florida Chiropractic Association’s (FCA) Northeast Regional Convention and Expo, held at the World Golf Renaissance in St. Augustine, FL. Excite was one of dozens of vendors and ...
-
Excite Medical displays the DRX9000 at Arab Health 2020
Excite Medical, the leading provider of non-surgical spinal decompression machines for back pain and neck pain, showcases the DRX9000® spinal decompression unit at Arab Health 2020 held at the Dubai World Trade Center. The DRX9000® non-surgical spinal decompression machine, grasped many distributors, hospital owners and doctors attention with its remarkable highly advanced technology and ...
-
ASTM F1582 - 98(2011) Standard Terminology Relating to Spinal Implants
1. Scope 1.1 This terminology covers basic terms and considerations for spinal implant devices and their mechanical analyses. 2. Referenced Documents (purchase separately) ASTM Standards E6 Terminology Relating to Methods of Mechanical Testing E1150 Definitions of Terms Relating to Fatigue Index Terms 0 Spinal implants; Terminology--medical/surgical systems/applications ICS ...
-
Excite Medical Impresses Field with DRX9000, an Advanced Spinal Decompression Machine, at Major Industry Event
Excite Medical recently displayed their groundbreaking spinal decompression machine at the Orlando Parker Seminar in Kissimmee, FL. Among dozens of products, the DRX9000 spinal decompression machine impressed healthcare and chiropractic professionals with its ability to alleviate chronic back and neck pain while simultaneously improving the wellbeing of patients. Excite was one of many vendors ...
-
RIVANNA Announces Partnership with BOMImed to Increase Distribution of Accuro in Canada
RIVANNA®, developers of world-first, imaging-based medical solutions, announced they have entered into a partnership with BOMImed, a recognized manufacturer of anesthesia and critical care related consumables to represent and distribute the Accuro® portfolio of products in Canada. BOMIMED is a choice distribution partner for RIVANNA as its focus is within the fields of anesthesia and ...
-
New Clinic in Turkey with Exoskeleton
There is an opportunity to undergo rehabilitation course with ExoAtlet for all patients who require rehabilitation from the effects of stroke, spinal cord injury, multiple sclerosis, cerebral palsy in Turkey. We have partnered with Romatem – the first and only medical center in Turkey specializing in the field of physiotherapy and rehabilitation. For more than 12 years the center have been ...
By ExoAtlet
-
Wenzel Spine Announces Acquisition of Interspinous & Facet Fixation Product Platforms
Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, today announced that it has completed the acquisition of the PrimaLOK™ SP Interspinous Fusion System and PrimaLOK™ FF Facet Fixation System from OsteoMed, LLC. The PrimaLOK SP & FF platforms include a polyaxial interspinous process device and ...
-
Differences Between Spinal Blocks & Epidurals
The biggest difference between spinal blocks vs epidurals is their amount of pain relief: spinal blocks provide total pain relief, while epidurals provide partial pain relief. The reason for this difference is that the former is an anesthetic, while the latter is an analgesic—no sensation versus no pain. But pain elimination comes with a total lack of feeling in the lower body, due to ...
-
The future of rehabilitation
Congratulations to the ONWARD team for the incredible progress they are making in the field of neuroengineering! In recent days, numerous media have reported the news of a great advance for science, and especially for all those people with spinal cord injury and their medical and caregiver teams. The ONWARD team has developed an epidural electrical stimulation system using electrodes placed ...
-
Carlsmed and the International Spine Study Group Foundation Announce Long-term Partnership
CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc., a commercial stage medical device technology company, is announcing today that it has partnered with the International Spine Study Group Foundation (ISSGF), the premier study group on adult spinal deformity, to collect data on surgical treatment with personalized interbody devices. Long term outcomes data will be collected to assess the role of ...
-
Saluda Medical Announces $125M Equity Financing Led by Redmile Group LLC and New Investors Fidelity Management & Research Company LLC and T. Rowe Price Associates, Inc.
Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, earlier this quarter finalized US $125 million in equity financing, led by existing investor Redmile Group LLC as well as ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you